News

Exciting Developments in Radiology: New CPT Codes Unveiled

Exciting Developments in Radiology: New CPT Codes Unveiled

RFA For Life Unveils New CPT Codes for Thyroid Treatments

These new codes enhance reimbursement pathways, expanding options for patients seeking thyroid care.

RFA For Life recently announced that the American Medical Association (AMA) has introduced new Category 1 CPT codes specifically for the radiofrequency ablation (RFA) of thyroid nodules. This change, effective from January 2025, is a significant advancement for both patients and healthcare providers, marking an important shift towards increasing access to non-surgical thyroid treatments.

Understanding the New CPT Codes

Thyroid RFA is a minimally invasive procedure that allows for the treatment of thyroid nodules effectively and safely. The newly established CPT codes, 60660 and 60661, provide clarity in billing and promote broader insurance coverage. Code 60660 refers to the ablation of one or more thyroid nodules, while 60661 pertains to additional nodules located in another lobe, ensuring that appropriate services provided are accurately documented and reimbursed.

Benefits of Radiofrequency Ablation

This innovative technique minimizes the need for surgical interventions, making it a preferred choice for many patients. The RFA procedure is generally performed under local anesthesia, ensuring patient comfort and safety. Typically lasting between 30 to 60 minutes, the procedure allows for patients to monitor their recovery with a brief observation period of 60 to 120 minutes before being discharged.

Clinical studies indicate remarkable outcomes, with patients experiencing up to an 80% reduction in nodule volume within a year—all while maintaining their normal thyroid function. This excellence in patient care underscores why physicians are increasingly adopting thyroid RFA.

Enhancing Patient Access to Care

The establishment of these codes aims to streamline the reimbursement process significantly. With enhanced data collection mechanisms, RFA’s integration into everyday medical practices among various specialists—including endocrinologists and interventional radiologists—will lead to more effective patient care management. As RFA becomes widely accepted, the importance of these new codes cannot be overstated.

Commitment to Education and Advocacy

RFA For Life remains dedicated to educating healthcare professionals and advocating for patients exploring alternatives to traditional thyroid surgeries. Resources available through RFA For Life empower both patients and physicians to make informed decisions regarding their treatment options, especially as they relate to RFA.

Stay Informed with RFA For Life

For those interested in discovering more about the advantages of thyroid radiofrequency ablation and finding specialists who perform this lifesaving procedure, RFA For Life encourages visits to their website and social media channels. Engaging with RFA For Life opens doors to insightful information and the latest advancements in thyroid care.

About RFA For Life

RFA For Life is committed to spreading awareness and education about radiofrequency ablation for benign thyroid nodules. By providing valuable resources and training for healthcare professionals, RFA For Life plays a pivotal role in the evolution of thyroid treatment.

Frequently Asked Questions

What are the new CPT codes introduced by the AMA?

The new CPT codes include 60660 for the ablation of one or more thyroid nodules, and 60661 for additional nodules in different lobes.

How does thyroid RFA work?

Thyroid RFA uses radiofrequency energy to reduce the size of benign thyroid nodules, allowing for an effective treatment option without surgery.

What is the recovery time after a thyroid RFA?

Patients typically recover within a few hours, remaining under observation for 60-120 minutes before discharge.

Why is there a need for new CPT codes?

New CPT codes streamline billing, enhance data collection, and increase insurance coverage for thyroid RFA procedures.

How can I learn more about thyroid RFA?

Visit the RFA For Life website or follow them on social media for more information and resources related to thyroid RFA care.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Veritran's Bold Move: Acquiring PrismaCampaigns Inc.

Updated Category News Views 111

Veritran's Strategic Leap Forward They're not messing around, folks. Veritran just made a power move by acquiring 100% of PrismaCampaigns Inc., and it’s more than just another day in the office. This marks a pivotal expansion of their American footprint, and they're zeroing in on our banks and credit unions with laser precision. Why This Matters for Financial...

Continue Reading
Kos & FORTH Partner to Spark Greek Biotech Growth

Updated Category News Views 81

New Frontiers: Greece on the Biotech Map Partnerships in biotech aren't tossed out willy-nilly; they're crafted for precision much like a sculptor shaping marble. Kos Biotechnology Partners and the Foundation for Research and Technology-Hellas (FORTH) are doing exactly that, teaming up to birth a biotechnology incubator on the FORTH campus in Heraklion, Crete. Now tell...

Continue Reading
AdMaven's Mave AI: Revolutionizing Campaign Management

Updated Category News Views 161

Taking the Tedious Out of Advertising You've got to love it when technology actually makes life easier, rather than more complicated. AdMaven's latest fancy toy, the AI assistant Mave, is promising just that. It's designed to take the heavy lifting off advertisers' shoulders, especially the day-to-day grind of tweaking ad settings and monitoring performance. If you've...

Continue Reading
Teledyne LeCroy Drives AI Scale-up with New UALink

Updated Category News Views 99

Pushing the Boundaries of AI Infrastructure Teledyne LeCroy is shaking things up with their latest innovation—the Xena Z2244 Ultra Accelerator Link™ Traffic Generator, a tool that promises to turbocharge validation systems for AI and HPC scale-up infrastructure. If you're dealing with the nuts and bolts of next-gen networks, this one's worth your attention. Setting a...

Continue Reading
Daymond John's Four-Center Bet on Longevity Game

Updated Category News Views 210

A Shark's Dive into Longevity Here you go—Daymond John, the face of FUBU and a household name from Shark Tank, is not just talking about living longer; he's putting his wallet where his words are. John is jumping into the longevity game with both feet, joining Ultimate Longevity Center's (ULC) latest venture. We're talking about four new centers across California,...

Continue Reading
NeuroPace Faces Investigation After Revenue Forecast Cut

Updated Category News Views 35

NeuroPace Revenue Drama: A Blow to Investor Confidence How the mighty have stumbled—or so it feels to the folks who put their bucks into NeuroPace, Inc. (NASDAQ: NPCE). It's tough to swallow: they cut their 2026 revenue forecast from a hopeful $99.5-$101.5 million to a sobering $91-$92 million. Just one quarter apart those projections are, like a cruel twist of fate...

Continue Reading
Choate's Expands to New Mid-South Markets

Updated Category News Views 128

Family Traditions Drive Choate's Growth Back in the day, you might've thought the family-run businesses were a dying breed, right? Not in the case of Choate's Air Conditioning, Heating, Plumbing & Electrical. These folks aren't just holding the fort; they're storming new territories across the Mid-South like they've got something to prove—or maybe just something to...

Continue Reading
Investors, Portillo's Fraud Claims Demand Your Attention

Updated Category News Views 71

Portillo's Investors Caught in a Tough Spot Ah, Portillo's. You thought those hot dogs were the only spicy thing you're biting into? Try these allegations on for size. Investors are biting back with a securities fraud lawsuit, and the details are saltier than a bucket of fries. The folks who held PTLO shares between September 19, 2023, and May 4, 2026, are in the...

Continue Reading
Ontario Airport Braces for Holiday Travel Surge

Updated Category News Views 126

Gearing Up for a Thanksgiving Travel Boom Think Thanksgiving brings only turkey to the table? Down in Ontario, California, it's all about jet fuel and passenger counts. The Ontario International Airport (ONT) is where the skies are buzzing, forecasting over 227,000 passengers trying to soak up the holiday vibes by air. Compare that to the numbers when the local folks...

Continue Reading
IQSTEL's Nine-Month Revenue Hits $313M, Growth Impresses

Updated Category News Views 203

Pushing Through With Persistence Well, well, well, here we are, talking about IQSTEL Inc. (NASDAQ: IQST) slinging some serious numbers—not the kind you can ignore at your breakfast table. The company pulled in a whopping $313 million in revenue over the first nine months of 2026. That’s a bump up by 34.5% from last year’s $232.7 million. What’s behind the magic...

Continue Reading

Top 5 Most Recently Viewed Articles

Alvotech's Proposed Biosimilar AVT06 Gains EMA Recommendation

Updated Category News Views 266

Positive News from the European Medicines Agency Alvotech (NASDAQ: ALVO), a pioneering biotech firm dedicated to manufacturing biosimilar medications, alongside Advanz Pharma, has recently received encouraging news from the European Medicines Agency (EMA). The Committee for Medicinal Products for Human Use (CHMP) has adopted a favorable opinion recommending the approval...

Continue Reading
Legal Action Alert: Zeta Global Holdings Corp. Investor Rights

Updated Category News Views 152

Legal Action Alert for Zeta Global Holdings Corp. Investors Rosen Law Firm, an established advocate for investor rights, is calling on shareholders of Zeta Global Holdings Corp. (NYSE: ZETA) who have experienced significant losses to get in touch with them. This notice comes in light of a newly filed class-action lawsuit that represents those who purchased Zeta securities...

Continue Reading
Stagwell Inc. Reports Impressive Financial Growth Results

Updated Category News Views 207

Stagwell Inc. Reports Impressive Financial Growth Results Stagwell Inc. (NASDAQ: STGW) has released its financial results for the recent quarter and the full year, showcasing an impressive performance. The report reveals not only year-on-year growth in revenue but also advances in digital transformation, highlighting the company’s robust market position. Fourth Quarter...

Continue Reading
BlocScale Launchpad Advances Tokenization on XRP Ledger

Updated Category News Views 259

Revolutionizing Tokenization with BlocScale Launchpad LIJA, Malta — The BlocScale Launchpad is making headlines by introducing a transformative approach to real-world asset (RWA) tokenization on the XRP Ledger. As a pioneering launchpad for Web3 projects and businesses emerging from various markets, it is gaining traction and establishing itself as a vital platform for...

Continue Reading
Analyzing Vale SA's Current Market Trajectory and Sentiment

Updated Category News Views 93

Exploring Vale SA's Trading Dynamics Vale SA's (NYSE: VALE) recent short interest report reveals a decrease of 6.55% in the short interest as a percentage of float. Currently, there are approximately 66.85 million shares sold short, which constitutes about 1.57% of the shares available for trading. This implies that, on average, it would take around 2.4 days for traders...

Continue Reading